[1] Milano MT, Chmura SJ, Garofalo MC, et al. Intensity-modulatedrad iotherapy in treatment of pancreatic and bile duct malignancies:toxicity and clinical outcome. Int J Radiat Oncol Biol Phys, 2004,59(2):445-453.
[2] Willett CG, Safran H, Abrams RA, et al. Clinical research in pancreatic cancer:the radiation therapy oncology group trials. Int J Radiat Oncol Biol Phys, 2003, 56(4 Suppl):31-37.
[3] Brenner DJ, Hall EJ. Stereotactic radiotherapy of intracranial tumor:An ideal candidate for accelerated treatment. Int J Radiat Oncol Biol Phys, 1994, 28(3):1039-1041.
[4] Tokuye K, Sumi M, Kagami Y, et al. Small-field radiotherapy in combination with concomitant chemotherapy for locally advanced pancreatic carcinoma. Radiother Oncol, 2003, 67(2):327-330.
[5] Martenson JA, Vigliotti AP, Pitot HC, et al. A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 2003, 55(4):1305-1310.
[6] 吴荣,贾明轩,郭启勇.三维适形放射治疗对局部中晚期胰腺癌的临床意义.中国医科大学学报,2004,33(1):142-146.
[7] van Geenen RC, Keyzer-Dekker CM, van Tienhoven G, et al. Pain management of patients with unresectable peripancreatic carcinoma. World J Surg, 2002, 26(6):715-720.